Join the National Foundation for Infectious Diseases (NFID) for a discussion on the importance of respiratory vaccination among pregnant women and immunocompromised individuals. Speakers will discuss current US immunization recommendations for COVID-19, influenza (flu), respiratory syncytial virus (RSV), and pneumococcal disease, disparities in immunization coverage, and provide effective strategies to increase immunization rates.
NFID Medical Director Robert (Bob) H. Hopkins, Jr., MD, will moderate the discussion with NFID Vice President Kevin A. Ault, MD, Chair and Professor of Obstetrics and Gynecology at Western Michigan University Homer Stryker MD School of Medicine, and Camille N. Kotton, MD, Clinical Director of Transplant and Immunocompromised Host Infectious Diseases at Massachusetts General Hospital.
At the conclusion of the activity, participants will be able to:
- Discuss current evidence-based recommendations for COVID-19, influenza, RSV, and pneumococcal vaccines among pregnant women and immunocompromised individuals
- Discuss disparities in respiratory immunization rates among pregnant women and immunocompromised individuals
- Identify practical strategies to increase respiratory immunization rates among pregnant women and immunocompromised individuals
There is no fee to participate in this activity, but pre-registration is required:
The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
NFID designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.